{
     "PMID": "17568429",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20071129",
     "LR": "20070709",
     "IS": "0887-4476 (Print) 0887-4476 (Linking)",
     "VI": "61",
     "IP": "9",
     "DP": "2007 Sep",
     "TI": "Alterations in dendritic morphology of hippocampal neurons in adult rats after neonatal administration of N-omega-nitro-L-arginine.",
     "PG": "785-9",
     "AB": "The dendritic length and dendritic-spine density of the pyramidal neurons of the prefrontal cortex and the CA1 hippocampus of rats using the nonselective nitric oxide synthase inhibitor N-omega-nitro-L-arginine (L-NNA) at different postnatal day (P) periods of the brain development (P1-P3, P4-P6, and P7-P9) were assessed using Golgi-Cox staining after puberty (P60). At P4-P6, the L-NNA treatment produced a significant decrease of the dendritic length and dendritic-spine density of the pyramidal cells of the CA1 hippocampus. In addition, the dendritic length of the pyramidal neurons of the CA1 hippocampus decreased because of the L-NNA treatment at P1-P3. These data suggest that during a specific step in the development of the brain, the nitric oxide levels may play a critical role in the morphological modifications of the pyramidal neurons of the CA1 hippocampus at postpubertal age.",
     "FAU": [
          "Morales-Medina, Julio Cesar",
          "Mejorada, Alejandro",
          "Romero-Curiel, Alejandra",
          "Flores, Gonzalo"
     ],
     "AU": [
          "Morales-Medina JC",
          "Mejorada A",
          "Romero-Curiel A",
          "Flores G"
     ],
     "AD": "Laboratorio de Neuropsiquiatria, Instituto de Fisiologia, Universidad Autonoma de Puebla, Puebla, Mexico.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Synapse",
     "JT": "Synapse (New York, N.Y.)",
     "JID": "8806914",
     "RN": [
          "0 (Enzyme Inhibitors)",
          "2149-70-4 (Nitroarginine)",
          "EC 1.14.13.39 (Nitric Oxide Synthase Type I)"
     ],
     "SB": "IM",
     "MH": [
          "Age Factors",
          "Animals",
          "Animals, Newborn",
          "Dendrites/*drug effects/ultrastructure",
          "Enzyme Inhibitors/*pharmacology",
          "Female",
          "Hippocampus/*cytology/drug effects/*growth & development",
          "Male",
          "Nitric Oxide Synthase Type I/*antagonists & inhibitors",
          "Nitroarginine/analogs & derivatives/pharmacology",
          "Pregnancy",
          "Pyramidal Cells/*cytology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Silver Staining/methods"
     ],
     "EDAT": "2007/06/15 09:00",
     "MHDA": "2007/12/06 09:00",
     "CRDT": [
          "2007/06/15 09:00"
     ],
     "PHST": [
          "2007/06/15 09:00 [pubmed]",
          "2007/12/06 09:00 [medline]",
          "2007/06/15 09:00 [entrez]"
     ],
     "AID": [
          "10.1002/syn.20406 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Synapse. 2007 Sep;61(9):785-9. doi: 10.1002/syn.20406.",
     "term": "hippocampus"
}